Ads
related to: novartis pharmaceuticals news- What Is TREMFYA®
Get Info On TREMFYA®
Learn More Today
- TREMFYA® Patient Support
Questions About Getting or Staying
on TREMFYA®? We Have Your Answers.
- TREMYFA® Dosing Timeline
Learn About a Dosing Schedule
and Administration Options.
- What Is A Biologic?
Learn About a Biologic Treatment
Option And How It Is Given.
- How TREMFYA® Works
Learn About TREMFYA®
Get Safety & Product Info.
- Visit Physician Website
Are You a Healthcare Professional?
Find HCP-Specific Information.
- What Is TREMFYA®
Search results
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 6 days agoPharmaceutical companies have tended to look for relatively smaller-size deals to brace for their...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoShares of the three pharma giants closed 1% higher. (helena.smolak@wsj.com) 1133 ET – Roche’s earnings are...of 40 basis points in 2024-28, compared with...
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 3 days agoHowever, Schmachtenberg says lesser government involvement and a lack of “overzealous regulation” in...
Campbell hires lawyer to head affordability unit - The Boston Globe
The Boston Globe· 6 days agoA former longtime executive at the Swiss drug giant Novartis will become the new chief executive of...
Goldman Sachs initiates cover on six European pharma stocks
Investing.com· 5 days agoGoldman Sachs initiates cover on six European pharma stocks
How Michael Cohen Made $4 Million Swimming In Trump's Swamp
Forbes· 6 days agoMichael Cohen made good money at the Trump Organization, earning more than a half million dollars a...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoCHICAGO, June 2, 2024 /PRNewswire/ -- 2Flo Ventures, an emerging venture capital firm and startup studio focused on the discovery, development, and commercialization of healthcare solutions ...
Triglycerides Down With ANGPTL3 RNA Interference Agent
MedPage Today· 6 days agoAn RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used atop usual statins ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoDr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute PR Newswire CAMBRIDGE, Mass., May 28, 2024 CAMBRIDGE, Mass., May 28, 2024 /PRNewswire/ -- The Bill & Melinda Gates Medical Research
How ‘Selling Out’ helped psychedelic MDMA
San Jose Mercury News· 12 hours agoRick Doblin first dreamed of the therapeutic potential of the psychedelic drug MDMA in a hippie house in downtown Santa Cruz, in an era when fears of bad...
